Association of 5' upstream promoter region of prostacyclin synthase gene variant with cerebral infarction.

T. Nakayama,M. Soma,D. Rehemudula,Y. Takahashi,H. Tobe,M. Satoh,J. Uwabo,M. Kunimoto,K. Kanmatsuse

DOI: https://doi.org/10.1016/S0895-7061(00)01216-4

2000-12-01

American Journal of Hypertension

Abstract:

What problem does this paper attempt to address?

Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma

Changbiao Li,Xiao Xu

DOI: https://doi.org/10.1007/s00018-019-03215-0

IF: 8

2019-01-01

Cellular and Molecular Life Sciences

Abstract:Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, with a high mortality rate. Its dismal prognosis is attributed to late diagnosis, high risk of recurrence and drug resistance. To improve the survival of patients with HCC, new approaches are required for early diagnosis, real-time monitoring and effective treatment. Exosomes are small membranous vesicles released by most cells that contain biological molecules and play a great role in intercellular communication under physiological or pathological conditions. In cancer, exosomes from tumor cells or non-tumor cells can be taken up by neighboring or distant target cells, and the cargoes in exosomes are functional to modulate the behaviors of tumors or reshape tumor microenvironment (TME). As essential components, non-coding RNAs (ncRNAs) are selectively enriched in exosomes, and exosomal ncRNAs participate in regulating specific aspects of tumor development, including tumorigenesis, tumor metastasis, angiogenesis, immunomodulation and drug resistance. Besides, dysregulated exosomal ncRNAs have emerged as potential biomarkers, and exosomes can serve as natural vehicles to deliver tumor-suppressed ncRNAs for treatment. In this review, we briefly summarize the biology of exosomes, the functions of exosomal ncRNAs in HCC development and their potential clinical applications, including as biomarkers and therapeutic tools.
The Biological Functions and Clinical Applications of Exosomes in Lung Cancer

Rui Chen,Xin Xu,Zijun Qian,Congcong Zhang,Yongjie Niu,Zhixian Wang,Jianli Sun,Xiao Zhang,Yongchun Yu

DOI: https://doi.org/10.1007/s00018-019-03233-y

IF: 8

2019-01-01

Cellular and Molecular Life Sciences

Abstract:Lung cancer remains the leading cause of cancer-related death worldwide, and the high incidence rates are worrisome. Exosomes are a class of extracellular vesicles secreted by most cells, including RNAs, proteins and lipids. Exosomes can mediate cell-to-cell communication in both physiologic and pathologic processes. Accumulated evidences show that cancer-derived exosomes aid in the recruitment and reprogramming of constituents correlated with tumor microenvironment. Furthermore, exosome-based clinical trials have been completed in advanced lung cancer patients. In this review, we discuss the roles of exosomes in a lung cancer microenvironment, such as its participation in lung cancer initiation, progression and metastasis as well as being involved in angiogenesis, epithelial-mesenchymal transition (EMT), immune escape, and drug resistance. In addition, we focus on the potential of exosomes as diagnostic and prognostic biomarkers in lung cancer, as well as the challenges faced by and advantages of exosomes as drug delivery vehicles and in exosome-based immunotherapy.
The role of exosomes in lung cancer metastasis and clinical applications: an updated review

Lei Yin,Xiaotian Liu,Xuejun Shao,Tao Feng,Jun Xu,Qi Wang,Shenghao Hua

DOI: https://doi.org/10.1186/s12967-021-02985-1

IF: 8.44

2021-07-19

Journal of Translational Medicine

Abstract:Abstract Lung cancer is the leading cause of cancer-associated deaths accounting for 24% of all cancer deaths. As a crucial phase of tumor progression, lung cancer metastasis is linked to over 70% of these mortalities. In recent years, exosomes have received increasing research attention in their role in the induction of carcinogenesis and metastasis in the lung. In this review, recent studies on the contribution of exosomes to lung cancer metastasis are discussed, particularly highlighting the role of lung tumor-derived exosomes in immune system evasion, epithelial-mesenchymal transition, and angiogenesis, and their involvement at both the pre-metastatic and metastatic phases. The clinical application of exosomes as therapeutic drug carriers, their role in antitumor drug resistance, and their utility as predictive biomarkers in diagnosis and prognosis are also presented. The metastatic activity, a complex multistep process of cancer cell invasion, survival in blood vessels, attachment and subsequent colonization of the host's organs, is integrated with exosomal effects. Exosomes act as functional mediating factors in cell–cell communication, influencing various steps of the metastatic cascade. To this end, lung cancer cell-derived exosomes enhance cell proliferation, angiogenesis, and metastasis, regulate drug resistance, and antitumor immune activities during lung carcinogenesis, and are currently being explored as an important component in liquid biopsy assessment for diagnosing lung cancer. These nano-sized extracellular vesicles are also being explored as delivery vehicles for therapeutic molecules owing to their unique properties of biocompatibility, circulatory stability, decreased toxicity, and tumor specificity. The current knowledge of the role of exosomes highlights an array of exosome-dependent pathways and cargoes that are ripe for exploiting therapeutic targets to treat lung cancer metastasis, and for predictive value assessment in diagnosis, prognosis, and anti-tumor drug resistance.

medicine, research & experimental
The biology, function and clinical implications of exosomes in lung cancer

Li Zhou,Tangfeng Lv,Qun Zhang,Qingqing Zhu,Ping Zhan,Suhua Zhu,Jianya Zhang,Yong Song

DOI: https://doi.org/10.1016/j.canlet.2017.08.003

2017-10-28

Abstract:Exosomes are 30-100 nm small membrane vesicles of endocytic origin that are secreted by all types of cells, and can also be found in various body fluids. Increasing evidence implicates that exosomes confer stability and can deliver their cargos such as proteins and nucleic acids to specific cell types, which subsequently serve as important messengers and carriers in lung carcinogenesis. Here, we describe the biogenesis and components of exosomes mainly in lung cancer, we summarize their function in lung carcinogenesis (epithelial mesenchymal transition, oncogenic cell transformation, angiogenesis, metastasis and immune response in tumor microenvironment), and importantly we focus on the clinical potential of exosomes as biomarkers and therapeutics in lung cancer. In addition, we also discuss current challenges that might impede the clinical use of exosomes. Further studies on the functional roles of exosomes in lung cancer requires thorough research.
Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy

Ziyu Jiang,Yun He,Wenlong Ding,Siyao Zhu,Qinyuan Li,Xiuchun Sun,Meiguang Bian,Jiege Huo

DOI: https://doi.org/10.1155/2022/8402500

IF: 3.791

2022-03-22

Journal of Nanomaterials

Abstract:Nonsmall cell lung carcinoma (NSCLC) is the leading cause of deaths related to carcinomas of lung by the involvement of several risk factors. Tumor cells, in general, exude larger quantities of biological macromolecules in comparison to their noncancerous opposites. Vesicular bodies or cavities created by the folding back of endosome membranes mingle with the plasma membrane and result in the release of exosomes into the extracellular space after which they enter proximal or distant cells of target. Exosomes are nanovesicles that can carry microRNAs (miRNAs) and other such macromolecules as cargos into the tumor environment by means of cell-to-cell communication. These materials transported by exosomes can act as indicators for oncogenesis and metastasis and result in resistance among therapy-sensitive cancer cells. The cargos inside the vesicles loaded with miRNAs vary according to their particular state and therefore can act as potential prognostic or diagnostic markers for a variety of diseases including lung cancer, especially NSCLC. Although the roles of exosomal miRNAs are unclear or contradictory, the possibility of using exosomes as efficient nanovesicles for the treatment of NSCLC using biological molecules such as miRNA remains critical. Hence, this review focuses on the roles of exosomal and cell-free miRNA in NSCLC therapy at preclinical and clinical levels.

materials science, multidisciplinary,nanoscience & nanotechnology
Pharmacological and nutritional treatment trials in McArdle disease.

R. Quinlivan,R. Beynon

2007-07-01

Abstract:A systematic review of evidence for randomised controlled trials using pharmacologic and nutritional therapies in McArdle disease was undertaken. Primary outcome measures included any objective assessment of exercise endurance. Secondary outcome measures included changes in metabolic parameters, subjective measures such as quality of life scores and adverse outcomes. Ten randomised controlled trials were identified. Two trials low dose creatine (60 mg/kg/day) and oral sucrose 75 g prior to exercise demonstrated a positive effect.
Exosomal Long Non-Coding RNAs: Biological Properties and Therapeutic Potential in Cancer Treatment

Jie Luo,Yan Xiong,Pei-fen Fu,En-chun Li,Lei Qu,Xiao Fan,Zhi-jian Cai,Ai-fu Lin

DOI: https://doi.org/10.1631/jzus.b1900039

2019-01-01

Abstract:Exosomes and long non-coding RNAs (lncRNAs) are emerging as important elements contributing to a more comprehensive understanding of cancer development and progression. The discovery of lncRNAs in exosomes further indicates their bona fide biological functional roles in cancer development and drug resistance. In this review, we describe the biogenesis of exosomes and summarize the function of exosomal lncRNAs in the field of cancer research. These findings strikingly advance current knowledge of exosomal lncRNAs and suggest that they may be promising diagnostic biomarkers and therapeutic targets for cancer.
Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma

Zhao Yang,Shi Fu,Yongchao Li,Youfeng Liang,Mingxuan Hao,Rui Guo,Changyuan Yu,Zahid Hussain,Jinku Zhang,Haifeng Wang

DOI: https://doi.org/10.1016/j.cej.2023.148160

IF: 15.1

2023-12-25

Chemical Engineering Journal

Abstract:Despite enormous evolution in oncopharmacology, the non-small cell lung carcinoma (NSCLC) is still among the most aggressive and prevalent types of cancer. Late diagnosis and poor prognosis are among the various predisposing factors associated with low disease-free survival (DFS) and overall survival (OS) rates in NSCLC patients. Being a stable source of tumor-derived antigens, exosomes and exosomal components (e.g., miRNAs, lnRNAs, circRNAs, cDNA, or proteins) can be actualized as a next-generation diagnostic/prognostic marker for early diagnosis and prognosis of NSCLC. Extensive research has been done on invasive screening of NSCLC through solid biopsy, but the prime focus of this review is non-invasive screening of NSCLC through liquid biopsy. The genetic and proteomic dysregulation of exosomal components in various biofluids precisely correlates with cancer growth, metastasis, stagging, chemoresistance, recurrence, low DFS and OS rates, and poor prognosis of NSCLC. Owing to their unique functionalities inherited from the source cells, protection of drug(s) from degradation, and nanoscaled dimensions (50–150 nm), exosomes have also been exploited for targeted delivery of a variety of drugs to NSCLC cells/tissues. Exosomal nanotherapeutics have shown exceptional anticancer efficacy against NSCLC due to enhanced cell uptake, higher cytotoxicity, mitigated proliferation and migration, prolonged plasma half-life, specific biodistribution, and controlled release of antineoplastic agents. Despite holding great promise, more research needs to be done before translating the exosome-mediated diagnosis/prognosis and treatment of NSCLC to clinical settings. In addition, standard guidelines/protocols for isolation, purification, production, and quality control of exosomes need to be formalized for manufacturing of clinical-grade exosomes.

engineering, chemical, environmental
Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis

Ming-Yue Li,Li-Zhong Liu,Ming Dong

DOI: https://doi.org/10.1186/s12943-021-01312-y

IF: 37.3

2021-01-27

Molecular Cancer

Abstract:Abstract Lung cancer is often diagnosed at an advanced stage and has a poor prognosis. Conventional treatments are not effective for metastatic lung cancer therapy. Although some of molecular targets have been identified with favorable response, those targets cannot be exploited due to the lack of suitable drug carriers. Lung cancer cell-derived exosomes (LCCDEs) receive recent interest in its role in carcinogenesis, diagnosis, therapy, and prognosis of lung cancer due to its biological functions and natural ability to carry donor cell biomolecules. LCCDEs can promote cell proliferation and metastasis, affect angiogenesis, modulate antitumor immune responses during lung cancer carcinogenesis, regulate drug resistance in lung cancer therapy, and be now considered an important component in liquid biopsy assessments for detecting lung cancer. Therapeutic deliverable exosomes are emerging as promising drug delivery agents specifically to tumor high precision medicine because of their natural intercellular communication role, excellent biocompatibility, low immunogenicity, low toxicity, long blood circulation ability, biodegradable characteristics, and their ability to cross various biological barriers. Several studies are currently underway to develop novel diagnostic and prognostic modalities using LCCDEs, and to develop methods of exploiting exosomes for use as efficient drug delivery vehicles. Current status of lung cancer and extensive applicability of LCCDEs are illustrated in this review. The promising data and technologies indicate that the approach on LCCDEs implies the potential application of LCCDEs to clinical management of lung cancer patients.

oncology,biochemistry & molecular biology
The Role of Exosomes and Their Applications in Cancer

Yuju Zhou,Ying Zhang,Huan Gong,Siqi Luo,Yan Cui

DOI: https://doi.org/10.3390/ijms222212204

IF: 5.6

2021-01-01

International Journal of Molecular Sciences

Abstract:Exosomes are very small extracellular vesicles secreted by multiple cell types and are extensively distributed in various biological fluids. Recent research indicated that exosomes can participate in regulating the tumor microenvironment and impacting tumor proliferation and progression. Due to the extensive enrollment in cancer development, exosomes have become a focus of the search for a new therapeutic method for cancer. Exosomes can be utilized for the therapeutic delivery of small molecules, proteins and RNAs to target cancer cells with a high efficiency. Exosome-carried proteins, lipids and nucleic acids are being tested as promising biomarkers for cancer diagnosis and prognosis, even as potential treatment targets for cancer. Moreover, different sources of exosomes exhibit multiple performances in cancer applications. In this review, we elaborate on the specific mechanism by which exosomes affect the communication between tumors and the microenvironment and state the therapeutic and diagnostic applications of exosomes in cancers.
The role of exosomal lncRNAs in cancer biology and clinical management

Wuwen Zhang,Qinshi Wang,Yi Yang,Siyuan Zhou,Ping Zhang,Tongbao Feng

DOI: https://doi.org/10.1038/s12276-021-00699-4

2021-11-01

Abstract:Abstract Exosomes play a vital role in cell–cell communication within the cancer microenvironment. Exosomal long noncoding RNAs (lncRNAs) are important regulators in cancer development and are involved in multiple processes, including cancer cell proliferation, angiogenesis, metastasis, drug resistance, and immunomodulation. Changes in the levels of exosomal lncRNAs often appear with the occurrence and development of cancer. Therefore, exosomal lncRNAs can be used as biomarkers for cancer diagnosis and prognosis. Exosomal lncRNAs can also indicate the treatment response of patients receiving chemotherapy. Moreover, exosomal lncRNAs are potential therapeutic targets for cancer treatment. In this review, we summarize the role of exosomal lncRNAs in cancer biology as well as in clinical management. A more comprehensive and in-depth understanding of the role of exosomal lncRNAs in cancer may help us better understand the mechanism of cancer development and clinically manage cancer patients.

biochemistry & molecular biology,medicine, research & experimental
Exosomes in Head and Neck Squamous Cell Carcinoma

Cheng Xiao,Fang Song,Yu Long Zheng,Jiong Lv,Qiang Feng Wang,Nong Xu

DOI: https://doi.org/10.3389/fonc.2019.00894

IF: 4.7

2019-01-01

Frontiers in Oncology

Abstract:Exosomes are small membranous vesicles that contain proteins, lipids, genetic material, and metabolites with abundant information from parental cells. Exosomes carry and deliver bioactive contents that can reprogram the functions of recipient cells and modulate the tumor microenvironment to induce pathological events through cell-to-cell communication and signal transduction. Tumor-derived exosomes (TDEs) in head and neck squamous cell carcinoma (HNSCC) are involved in most aspects of cancer initiation, invasion, progression, immunoregulation, therapeutic applications, and treatment resistance. In addition, HNSCC-derived exosomes can be used to obtain information on diagnostic and therapeutic biomarkers in circulating blood and saliva. Currently, the biology, mechanisms, and applications of TDEs in HNSCC are still unclear, and further research is required. In this review, we discuss various aspects of exosome biology, including exosomal components, exosomal biomarkers, and molecular mechanisms involved in immunoregulation, cancer metastasis, and therapy resistance. We also describe recent applications to update our understanding of exosomes in HNSCC.
Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer

Ding-Yu Rao,De-Fa Huang,Mao-Yan Si,Hua Lu,Zhi-Xian Tang,Zu-Xiong Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1142539

IF: 7.3

2023-04-13

Frontiers in Immunology

Abstract:As an important mediator of information transfer between cells, exosomes play a unique role in regulating tumor growth, supporting vascular proliferation, tumor invasion, and metastasis. Exosomes are widely present in various body fluids, and therefore they can be used as a potential tool for non-invasive liquid biopsy. The present study reviews the role of exosomes in liquid biopsy, tumor microenvironment formation, and epithelial-mesenchymal transition in non-small cell lung cancer (NSCLC). By targeting epidermal growth factor receptor (EGFR) therapy as a first-line treatment for patients with NSCLC, this study also briefly describes the occurrence of EGRF+ exosomes and the role of exosomes and their contents in non-invasive detection and potential therapeutic targets in EGFR-mutated lung cancer.

immunology
Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application

Shang-Long Liu,Pin Sun,Ying Li,Shi-Song Liu,Yun Lu

DOI: https://doi.org/10.21037/tcr.2019.01.03

2019-02-01

Translational Cancer Research

Abstract:Exosomes are small membrane vesicles that measure 20 to 100 nm in diameter and are released by many cell types, including lymphocytes, dendritic cells (DCs) and tumor cells. As efficient messengers in cell-to-cell communication, exosomes released by tumors play an important role in regulating tumor malignancy. Tumor-derived exosomes contain proteins, mRNAs, and miRNAs, which can be delivered between different types of cells and even transferred to distant locations to influence the biological activities of tumors, such as proliferation, invasion and metastasis, immunoregulation, generation of a premetastatic niche and stimulation of angiogenesis. This review highlights advances in the understanding of exosome secretion and the role of exosomes in cancer molecular behavior. Moreover, we also discuss the potential clinical application of exosomes as biomarkers and therapeutic tools. Tumor-derived exosomes may represent a target for therapeutic intervention and for the development of early diagnostic biomarkers.

oncology
Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers

Runzhi Qi,Yuwei Zhao,Qiujun Guo,Xue Mi,Mengqi Cheng,Wei Hou,Honggang Zheng,Baojin Hua

DOI: https://doi.org/10.1186/s12935-021-01990-0

IF: 6.429

2021-06-30

Cancer Cell International

Abstract:Abstract Lung cancer is one of the most common malignant tumours worldwide. however, emerging immunotherapy and targeted therapies continue to show limited efficacy. In the search for new targets for lung cancer treatment, exosomes have become a major focus of research. Exosomes play an important role in the tumour microenvironment (TME) of lung cancer and affect invasion, metastasis, and treatment responses. This review describes our current understanding of the release of exosomes derived from different cells in the TME, the effects of exosomes on T/Tregs, myeloid-derived suppressor cells, tumour-associated macrophages, dendritic cells, and natural killer cells, and the role of exosomes in the endothelial–mesenchymal transition, angiogenesis, and cancer-associated fibroblasts. In particular, this review focuses on the potential clinical applications of exosomes in the lung cancer microenvironment and their prognostic and diagnostic value.

oncology
Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential

Hongze Lin,Jiaying Li,Maoye Wang,Xu Zhang,Taofeng Zhu

DOI: https://doi.org/10.7150/jca.84506

IF: 3.9

2023-01-01

Journal of Cancer

Abstract:Exosomes are a typical subset of extracellular vesicles (EVs) that can be transmitted from parent cells to recipient cells via human bodily fluids. Exosomes perform a vital role in mediating intercellular communication by shuttling bioactive cargos, such as nucleic acids, proteins and lipids. Long noncoding RNAs (lncRNAs) are transcripts longer than 200 nucleotides without protein translation ability and can be selectively packaged into exosomes. Accumulating evidence indicates that exosomal lncRNAs have a critical role in tumor initiation and progression through regulating tumor proliferation, apoptosis, invasion, metastasis, angiogenesis, treatment resistance and tumor microenvironment. Increasing studies suggest that exosomal lncRNAs have great potential to be served as novel targets and non-invasive biomarkers for diagnosis and prognosis in non-small cell lung cancer (NSCLC). In this review, we provide an overview of current research on the disordered functions of exosomal lncRNAs in NSCLC and summarize their potential clinical applications as diagnostic and prognostic biomarkers and therapeutic targets for NSCLC.

oncology
Exosomes: key players in cancer and potential therapeutic strategy

Jie Dai,Yangzhou Su,Suye Zhong,Li Cong,Bang Liu,Junjun Yang,Yongguang Tao,Zuping He,Chao Chen,Yiqun Jiang

DOI: https://doi.org/10.1038/s41392-020-00261-0

IF: 39.3

2020-08-05

Signal Transduction and Targeted Therapy

Abstract:Abstract Exosomes are extracellular vesicles secreted by most eukaryotic cells and participate in intercellular communication. The components of exosomes, including proteins, DNA, mRNA, microRNA, long noncoding RNA, circular RNA, etc., which play a crucial role in regulating tumor growth, metastasis, and angiogenesis in the process of cancer development, and can be used as a prognostic marker and/or grading basis for tumor patients. Hereby, we mainly summarized as followed: the role of exosome contents in cancer, focusing on proteins and noncoding RNA; the interaction between exosomes and tumor microenvironment; the mechanisms that epithelial-mesenchymal transition, invasion and migration of tumor affected by exosomes; and tumor suppression strategies based on exosomes. Finally, the application potential of exosomes in clinical tumor diagnosis and therapy is prospected, which providing theoretical supports for using exosomes to serve precise tumor treatment in the clinic.

biochemistry & molecular biology,cell biology
Exosomes and Their Role in Cancer Progression

Yang Liu,Ke Shi,Yong Chen,Xianrui Wu,Zheng Chen,Ke Cao,Yongguang Tao,Xiang Chen,Junlin Liao,Jianda Zhou

DOI: https://doi.org/10.3389/fonc.2021.639159

IF: 4.7

2021-03-22

Frontiers in Oncology

Abstract:Exosomes from extracellular vesicles can activate or inhibit various signaling pathways by transporting proteins, lipids, nucleic acids and other substances to recipient cells. In addition, exosomes are considered to be involved in the development and progression of tumors from different tissue sources in numerous ways, including remodeling of the tumor microenvironment, promoting angiogenesis, metastasis, and invasion, and regulating the immune escape of tumor cells. However, the precise molecular mechanisms by which exosomes participate in these different processes remains unclear. In this review, we describe the research progress of tumor cell-derived exosomes in cancer progression. We also discuss the prospects of the application of exosomes combined with nanoengineered chemotherapeutic drugs in the treatment of cancer.

oncology
Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances

Jianhua Zhao,Xiwen Li,Lele Liu,Zhen Zhu,Chunyan He

DOI: https://doi.org/10.3389/fimmu.2023.1326667

2023-12-14

Abstract:Lung cancer is a chronic wasting disease with insidious onset and long treatment cycle. Exosomes are specialized extracellular vesicles, at first exosomes were considered as a transporter of cellular metabolic wastes, but recently many studies have identified exosomes which contain a variety of biologically active substances that play a role in the regulation of cellular communication and physiological functions. Exosomes play an important role in the development of lung cancer and can promote metastasis through a variety of mechanisms. However, at the same time, researchers have also discovered that immune cells can also inhibit lung cancer through exosomes. In addition, researchers have discovered that some specific miRNAs in exosomes can be used as markers for early diagnosis of lung cancer. Engineering exosomes may be one of the strategies to enhance the clinical translational application of exosomes in the future, for example, strategies such as modifying exosomes to enhance targeting or utilizing exosomes as carriers for drug delivery have been explored. but more studies are needed to verify the safety and efficacy. This article reviews the latest research on exosomes in the field of lung cancer, from the mechanism of lung cancer development, the functions of immune cell-derived exosomes and tumor-derived exosomes, to the early diagnosis of lung cancer.
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Simona Taverna,Marco Giallombardo,Ignacio Gil-Bazo,Anna Paola Carreca,Marta Castiglia,Jorge Chacártegui,Antonio Araujo,Riccardo Alessandro,Patrick Pauwels,Marc Peeters,Christian Rolfo

DOI: https://doi.org/10.18632/oncotarget.7638

2016-02-23

Oncotarget

Abstract:Exosomes are nano-sized vesicles of endolysosomal origin, released by several cytotypes in physiological and pathological conditions. Tumor derived exosomes, interacting with other cells of the tumor microenvironment, modulate tumor progression, angiogenic switch, metastasis, and immune escape. Recently, extracellular vesicles were proposed as excellent biomarkers for disease monitoring and prognosis in cancer patients. Non-small cell lung cancer (NSCLC) has a poor 5-year survival rate due to the delay in the detection of the disease. The majority of patients are diagnosed in an advanced disease stage. Exosomes might be promising beneficial tools as biomarker candidates in the scenario of NSCLC, since they contain both, proteins and miRNAs. The clinical case reported in this manuscript is a proof of concept revealing that NSCLC exosomes and sorted miRNAs might constitute, in a near future, novel biomarkers. This review summarizes the role of exosomes in NSCLC, focusing on the importance of exosomal microRNAs in lung cancer diagnosis and prognosis.

Association of 5' upstream promoter region of prostacyclin synthase gene variant with cerebral infarction.

Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma

The Biological Functions and Clinical Applications of Exosomes in Lung Cancer

The role of exosomes in lung cancer metastasis and clinical applications: an updated review

The biology, function and clinical implications of exosomes in lung cancer

Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy

Pharmacological and nutritional treatment trials in McArdle disease.

Exosomal Long Non-Coding RNAs: Biological Properties and Therapeutic Potential in Cancer Treatment

Exosome as non-invasive prognostic and diagnostic biomarker and nanovesicle for targeted therapy of non-small cell lung carcinoma

Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis

The Role of Exosomes and Their Applications in Cancer

The role of exosomal lncRNAs in cancer biology and clinical management

Exosomes in Head and Neck Squamous Cell Carcinoma

Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer

Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application

Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers

Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential

Exosomes: key players in cancer and potential therapeutic strategy

Exosomes and Their Role in Cancer Progression

Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice